You are hereRecent Publications of Members of the Boston Ithaca Islet Club / N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake

N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake


By JPGRAY - Posted on 24 February 2009

TitleN-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake
Publication TypeJournal Article
Year of Publication2008
AuthorsGillum MP, Zhang D, Zhang XM, Erion DM, Jamison RA, Choi C, Dong J, Shanabrough M, Duenas HR, Frederick DW, Hsiao JJ, Horvath TL, Lo CM, Tso P, Cline GW, Shulman GI
JournalCell
Volume135
Issue5
Pagination813-24
Date PublishedNov 28
Publication Languageeng
ISBN Number1097-4172 (Electronic)
Accession Number19041747
Key WordsRats, Mice, Obese, Body Weight, Animals, Tandem Mass Spectrometry, Proto-Oncogene Proteins c-fos/metabolism, Phosphatidylethanolamines/blood/*physiology, Palmitic Acids/metabolism, Obesity/metabolism, Motor Activity, Intestine, Small/metabolism, Hypothalamus/metabolism, Dietary Fats/metabolism, *Appetite Regulation
Abstract

N-acylphosphatidylethanolamines (NAPEs) are a relatively abundant group of plasma lipids of unknown physiological significance. Here, we show that NAPEs are secreted into circulation from the small intestine in response to ingested fat and that systemic administration of the most abundant circulating NAPE, at physiologic doses, decreases food intake in rats without causing conditioned taste aversion. Furthermore, (14)C-radiolabeled NAPE enters the brain and is particularly concentrated in the hypothalamus, and intracerebroventricular infusions of nanomolar amounts of NAPE reduce food intake, collectively suggesting that its effects may be mediated through direct interactions with the central nervous system. Finally, chronic NAPE infusion results in a reduction of both food intake and body weight, suggesting that NAPE and long-acting NAPE analogs may be novel therapeutic targets for the treatment of obesity.

Notes

P30 DK-45735/DK/NIDDK NIH HHS/United StatesR01 DK-40936/DK/NIDDK NIH HHS/United StatesU24 DK-76169/DK/NIDDK NIH HHS/United StatesHoward Hughes Medical Institute/United StatesJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited States

URLhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19041747
Citation Key334
Export

Signup to receive email notifications of upcoming events

To signup to receive email notifications of upcoming BIIC events, fill out the information here.